⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL27587535 | 0.95 | — | — | |
| SCHEMBL12943155 | 0.95 | — | — | |
| SCHEMBL30460641 | 0.95 | — | — | |
| SCHEMBL25163 | 0.95 | — | — | |
| SCHEMBL10021534 | 0.95 | — | — | |
| SCHEMBL3257377 | 0.90 | — | — | |
| SCHEMBL30820024 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL28045283 | 0.90 | — | — | |
| Ammonia Solution, Strong SCHEMBL7699331 | 0.90 | — | — | |
| SCHEMBL30881928 | 0.90 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180318473-A1 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | ABRAXIS BIOSCIENCE LLC (US) | 2018-11-08 | — | — | US | disclosed |
| EP-3345632-A1 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | Abraxis BioScience, LLC (US) | 2018-07-11 | — | — | EP | disclosed |
| EP-3345631-A1 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | Abraxis BioScience, LLC (US) | 2018-07-11 | — | — | EP | disclosed |
| EP-1861070-B1 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | ABRAXIS BIOSCIENCE LLC (US) | 2018-01-17 | — | — | EP | disclosed |
| US-20170203012-A1 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | ABRAXIS BIOSCIENCE LLC (US) | 2017-07-20 | — | — | US | disclosed |
| CN-105879114-A | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | 阿布拉西斯生物科学公司 | 2016-08-24 | — | — | CN | disclosed |
| EP-2896412-A1 | Drugs with improved hydrophobicity for incorporation in medical devices | Abraxis BioScience, LLC (US) | 2015-07-22 | — | — | EP | disclosed |
| US-20150190556-A1 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | ABRAXIS BIOSCIENCE LLC (US) | 2015-07-09 | — | — | US | disclosed |
| US-20090130163-A1 | Drugs With Improved Hydrophobicity For Incorporation in Medical Devices | ABRAXIS BIO SCOENCE, INC. (US) | 2009-05-21 | — | — | US | disclosed |
| EP-1861070-A2 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | Abraxis BioScience, Inc. (US) | 2007-12-05 | — | — | EP | disclosed |
| WO-2007059116-A2 | GELDANAMYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | ABRAXIS BIOSCIENCE, INC. (US) | 2007-05-24 | — | — | WO | disclosed |
| WO-2006089207-A2 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | ABRAXIS BIOSCIENCE, INC. (US) | 2006-08-24 | — | — | WO | disclosed |